Jason Ryan
Vorsitzender bei GENEDX HOLDINGS CORP.
Vermögen: 4 Mio $ am 31.05.2024
Aktive Positionen von Jason Ryan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Direktor/Vorstandsmitglied | 01.04.2021 | - |
Independent Dir/Board Member | 01.04.2021 | - | |
GENEDX HOLDINGS CORP. | Independent Dir/Board Member | 22.07.2021 | - |
Vorsitzender | 18.01.2022 | - | |
Direktor/Vorstandsmitglied | 22.07.2021 | 18.01.2022 | |
Sema4, Inc.
Sema4, Inc. Investment ManagersFinance Sema4, Inc. provides general underwriting services. The company is headquartered in Unionville, CT. | Direktor/Vorstandsmitglied | 01.07.2021 | - |
Karriereverlauf von Jason Ryan
Ehemalige bekannte Positionen von Jason Ryan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STANDARD BIOTOOLS INC. | Vorsitzender | 28.03.2023 | 05.01.2024 |
Independent Dir/Board Member | 28.03.2023 | 05.01.2024 | |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Direktor/Vorstandsmitglied | 01.04.2020 | 01.10.2020 |
Independent Dir/Board Member | 01.04.2020 | 01.10.2020 | |
MAGENTA THERAPEUTICS | Geschäftsführer | 01.01.2019 | 01.10.2020 |
Finanzdirektor/CFO | 01.01.2019 | 01.10.2020 | |
FOUNDATION MEDICINE INC | Finanzdirektor/CFO | 01.05.2011 | 01.11.2018 |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Finanzdirektor/CFO | 01.05.2009 | - |
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Verwaltungsdirektor | 01.05.2007 | - |
Finanzdirektor/CFO | 01.05.2007 | - | |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Jason Ryan
Babson College | Masters Business Admin |
Bates College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Director of Finance/CFO | 5 |
Director/Board Member | 4 |
Independent Dir/Board Member | 4 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SINGULAR GENOMICS SYSTEMS, INC. | Health Technology |
GENEDX HOLDINGS CORP. | Health Services |
STANDARD BIOTOOLS INC. | Commercial Services |
Private Unternehmen | 8 |
---|---|
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Health Technology |
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Genomics Collaborative, Inc.
Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
ArcherDX LLC
ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Technology Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Sema4, Inc.
Sema4, Inc. Investment ManagersFinance Sema4, Inc. provides general underwriting services. The company is headquartered in Unionville, CT. | Finance |
- Börse
- Insiders
- Jason Ryan
- Erfahrung